Advertisement
UK markets close in 1 hour 42 minutes
  • FTSE 100

    8,058.34
    +17.96 (+0.22%)
     
  • FTSE 250

    19,590.90
    -128.47 (-0.65%)
     
  • AIM

    753.30
    -1.39 (-0.18%)
     
  • GBP/EUR

    1.1659
    +0.0014 (+0.12%)
     
  • GBP/USD

    1.2476
    +0.0014 (+0.11%)
     
  • Bitcoin GBP

    50,785.39
    -2,195.09 (-4.14%)
     
  • CMC Crypto 200

    1,366.26
    -16.31 (-1.18%)
     
  • S&P 500

    5,001.28
    -70.35 (-1.39%)
     
  • DOW

    37,872.89
    -588.03 (-1.53%)
     
  • CRUDE OIL

    82.62
    -0.19 (-0.23%)
     
  • GOLD FUTURES

    2,332.50
    -5.90 (-0.25%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,852.71
    -235.99 (-1.30%)
     
  • CAC 40

    7,973.75
    -118.11 (-1.46%)
     

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA (“HBC”), has today purchased 70,000 shares in HBC at an average price of NOK 9.294 per share.

As a result of the transaction, Mr. Baldegger holds 650,000 shares in HBC, equal to 0.18 % of the outstanding shares.

This information is subject of the disclosure requirements pursuant to sections 4-2 and 5-12 of the Norwegian Securities Trading Act.